- Home
- BDSX
BDSX
Biodesix Inc.
as of 12-10-2025 3:23pm EST
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | LOUISVILLE |
| Market Cap: | 53.0M | IPO Year: | 2020 |
| Target Price: | $32.50 | AVG Volume (30 days): | 65.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.44 - $32.20 | Next Earning Date: | 11-03-2025 |
| Revenue: | $80,173,000 | Revenue Growth: | 22.29% |
| Revenue Growth (this year): | 20.75% | Revenue Growth (next year): | 25.05% |
Stock Insider Trading Activity of Biodesix Inc. (BDSX)
Chief Accounting Officer
Avg Cost/Share
$7.62
Shares
13
Total Value
$99.06
Owned After
936
SEC Form 4
Chief Development Officer
Avg Cost/Share
$7.62
Shares
23
Total Value
$175.26
Owned After
7,939
SEC Form 4
CFO, Sec'y & Treasurer
Avg Cost/Share
$7.62
Shares
50
Total Value
$381.00
Owned After
13,147
SEC Form 4
Chief Commercial Officer
Avg Cost/Share
$7.62
Shares
25
Total Value
$190.50
Owned After
7,362
SEC Form 4
President & CEO
Avg Cost/Share
$7.62
Shares
189
Total Value
$1,440.18
Owned After
37,311
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$7.04
Shares
142,045
Total Value
$999,996.80
Owned After
1,380,745
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$6.17
Shares
3,056
Total Value
$18,853.99
Owned After
1,380,745
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$6.04
Shares
15,317
Total Value
$92,571.35
Owned After
1,380,745
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Vazquez Chris | BDSX | Chief Accounting Officer | Nov 10, 2025 | Sell | $7.62 | 13 | $99.06 | 936 | |
| Pestano Gary Anthony | BDSX | Chief Development Officer | Nov 10, 2025 | Sell | $7.62 | 23 | $175.26 | 7,939 | |
| Cowie Robin Harper | BDSX | CFO, Sec'y & Treasurer | Nov 10, 2025 | Sell | $7.62 | 50 | $381.00 | 13,147 | |
| O'Kane Kieran | BDSX | Chief Commercial Officer | Nov 10, 2025 | Sell | $7.62 | 25 | $190.50 | 7,362 | |
| Hutton Scott | BDSX | President & CEO | Nov 10, 2025 | Sell | $7.62 | 189 | $1,440.18 | 37,311 | |
| SCHULER JACK W | BDSX | Director, 10% Owner | Sep 19, 2025 | Buy | $7.04 | 142,045 | $999,996.80 | 1,380,745 | |
| SCHULER JACK W | BDSX | Director, 10% Owner | Sep 18, 2025 | Buy | $6.17 | 3,056 | $18,853.99 | 1,380,745 | |
| SCHULER JACK W | BDSX | Director, 10% Owner | Sep 17, 2025 | Buy | $6.04 | 15,317 | $92,571.35 | 1,380,745 |
Compare BDSX vs Leading Stocks
See how BDSX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "BDSX Biodesix Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.